- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
MRI contrast firm Epix files IPO
Epix Medical of Cambridge, MA, has filed a registration statementwith the Securities and Exchange Commission for an initial publicoffering of two million shares of stock, plus an overallotmentoption of 300,000 shares. Epix, formerly known as Metasyn, isa
Epix Medical of Cambridge, MA, has filed a registration statementwith the Securities and Exchange Commission for an initial publicoffering of two million shares of stock, plus an overallotmentoption of 300,000 shares. Epix, formerly known as Metasyn, isa developer of targeted contrast agents, including MS-325, a gadolinium-basedagent for MR angiography of coronary and peripheral arteries.
Epix has licensed rights to MS-325 and other MRI vascular agentsin all countries except Japan to Mallinckrodt of St. Louis (SCAN10/9/96). MS-325 has entered phase I clinical trials, and proceedsfrom Epix's IPO will help fund that work and will be used forgeneral corporate purposes.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.
